Fibrocell Science Inc buy melinda
Start price
09.09.17
/
50%
€2.90
Target price
19.12.17
€3.97
Performance (%)
-78.57%
End price
19.12.17
€0.62
Summary
This prediction ended on 19.12.17 with a price of €0.62. Massive losses of -78.57% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Fibrocell Science Inc | - | - | - | - |
iShares Core DAX® | -0.116% | 1.953% | 14.155% | 16.268% |
iShares Nasdaq 100 | -2.733% | -1.273% | 31.828% | 43.377% |
iShares Nikkei 225® | -1.721% | 3.263% | 12.922% | 8.501% |
iShares S&P 500 | -1.527% | 0.194% | 27.117% | 41.752% |
Comments by melinda for this prediction
In the thread Fibrocell Science Inc diskutieren
zu folgen
Phase 1/2 Einleitung der Therapie am 23. Februar angekündigt, 2017. Phase 1 Daten für 3Q 2017
(Vom Mitglied beendet)
Stopped prediction by melinda for Fibrocell Science Inc
Fibrocell Science Inc
Start price
Target price
Perf. (%)
€3.22
09.09.17
09.09.17
€4.40
19.12.17
19.12.17
-78.57%
19.12.17
19.12.17
Fibrocell Science Inc
Start price
Target price
Perf. (%)
€3.08
26.06.17
26.06.17
€3.43
27.06.17
27.06.17
11.70%
27.06.17
27.06.17